Article

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to in-Vivo Images

2021-08-18

Abstract excerpt

Lung cancer remains the leading cause of cancer-related death and it is usually diagnosed in advanced stages (stage III or IV). Recently, the availability of targeted strategies and of immunotherapy with checkpoint inhibitors (ICI) has favorably changed patient prognosis. Treatment outcome is closely related to tumor biology and interaction with the host immune microenvironment (TME). Whether for targeted therapie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2af33ca0-5da2-5496-a514-9ead7cb46819
DOI: 10.20944/preprints202108.0372.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to in-Vivo ImagesDOI 10.20944/preprints202108.0372.v1Read

How clinical imaging can assess cancer biologySemantic proximity Read

Computational biomarker predicts lung ICI response via deep learning-driven hierarchical spatial modelling from H&ESemantic proximity Read

Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patientsSemantic proximity Read

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.Semantic proximity Read

Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy responseSemantic proximity Read

Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesionsSemantic proximity Read

Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond.Semantic proximity Read

Non-invasive decision support for NSCLC treatment using PET/CT radiomics.Semantic proximity Read

Patient-Derived Three-Dimensional Lung Tumor Models to Evaluate Response to ImmunotherapySemantic proximity Read

Molecular Imaging in Immunotherapy: A Systematic ReviewSemantic proximity Read

Predictive Effect of Spatial Protein Signature in Advanced Non-small Cell Lung Cancer Patients Treated with Bispecific Antibody (KN046) ImmunotherapySemantic proximity Read